ИностранцамНовостиКонтакты
БОЛЬНИЦЫ УНИВЕРСИТЕТАХАДЖЕТТЕПЕ
Запись
RU
  1. Главная
  2. Врачи
  3. Проф. д-р Ömer Karadağ
Проф. д-р Ömer Karadağ

Проф. д-р

Ömer Karadağ

Ревматология · Больница для взрослых

Васкулитыультрасонография опорно-двигательной системырегистры пациентовсемейная средиземноморская лихорадкаартериит Такаясу
Записаться на приём

О враче

Окончил Газиантепский научный лицей и медицинский факультет Университета Хаджеттепе. Ординатуру по внутренним болезням (2000-2005) и субспециализацию по ревматологии (2005-2008) прошёл на медицинском факультете Университета Хаджеттепе.

С октября 2011 года начал работать преподавателем в отделении ревматологии кафедры внутренних болезней Хаджеттепе. В марте 2012 года ему присвоено звание доцента, в июле 2018 года — профессора.

Международные сертификаты и опыт

  • В октябре 2005 года сдал Board-экзамен по внутренним болезням, в мае 2010 года завершил онлайн-курс Европейской антиревматической лиги (EULAR).
  • В 2007 году после обучения ультрасонографии опорно-двигательной системы на кафедре ревматологии Университета Политехника делле Марке (Италия) получил право на сертификат.
  • В 2015 году получил сертификат преподавателя по МРТ крестцово-подвздошных суставов при спондилоартритах программы «Care Arthritis / Arthritis Research and Education in Canada».
  • С августа 2016 года по июль 2017 года работал клиническим фелло в клинике васкулитов и волчанки больницы Addenbrooke’s Кембриджского университета (Великобритания).

Награды

  • В 2004 году получил премию проф. д-ра Шерефа Зилели «Успешный ординатор года».
  • Получил премию Actelion по васкулопатиям (2008) и премию Abbott за лучшее исследование по ревматоидному артриту (2010).

Другие должности в стране

  • Военную службу прошёл в научном направлении ревматологии GATA в Анкаре.
  • В связи с обязательной государственной службой в феврале 2010 года был назначен в государственную больницу Диярбакыра, где создал клинику ревматологии и начал оказывать услуги. В этот период в качестве основателя-заместителя главного врача Учебно-исследовательской больницы Диярбакыра активно участвовал в планировании и открытии больницы.

Административные должности и профессиональные организации

  • Участвовал в создании Центра диагностики и лечения васкулитов Университета Хаджеттепе (HUVAM). Продолжает руководить центром, на должность директора-основателя которого был назначен в июле 2014 года.
  • Является членом правления Центра клинических исследований Хаджеттепе (HÜKAM).
  • В Турецком обществе ревматологии в 2012-2016 годах работал в правлении, в 2016-2018 годах — в ревизионной комиссии, а с 2018 года является членом Научного совета.
  • Является членом правления Ревматологического общества Хаджеттепе.
  • Является членом Европейской рабочей группы по васкулитам (EUVAS) и Турецкого общества специалистов по внутренним болезням.
  • Работает председателем правления Ассоциации образования и социальной солидарности по внутренним болезням Хаджеттепе.

Сферы работы и исследований, деятельность в научных журналах

  • Является заместителем редактора журнала RAED и входит в редколлегию «Journal of Vasculitis».
  • Занимается воспалительными ревматическими заболеваниями, в первую очередь ревматоидным артритом, анкилозирующим спондилитом, системной красной волчанкой, болезнью Бехчета, семейной средиземноморской лихорадкой и васкулитами.
  • Сферы исследований: васкулиты, IgG4-связанные заболевания, артериит Такаясу, ультрасонография опорно-двигательной системы, МРТ крестцово-подвздошных суставов, системы регистрации пациентов и семейная средиземноморская лихорадка.

Образование

  1. 2008
    Докторантура — Ревматология
    Ревматология
  2. 2005
    Магистратура — Внутренние болезни
    Внутренние болезни
  3. 2000
    Медицина
    Хаджеттепе
  4. 1994
    Научный лицей Газиантеп

Области специализации

Васкулитыультрасонография опорно-двигательной системырегистры пациентовсемейная средиземноморская лихорадкаартериит Такаясу

Публикации

Источник: Система управления академическими данными Университета Хаджеттепе (AVESİS) · Все публикации (216) ↗

Articles 73

  1. Obexelimab for the Treatment of IgG4-Related DiseaseDella-Torre E., Baker M. C., Zhang W., Perugino C. A., Katz G., Tanaka Y., et al.The New England journal of medicine, cilt.395, sa.13, ss.1273-1284, 2026 (SCI-Expanded, Scopus)
  2. Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysisÇAKIR İ. Y., BİLGİN E., FIRLATAN YAZGAN B., EKİCİ M., Bayram G. S. K., ÜNALDI E., et al.Clinical Rheumatology, cilt.45, sa.9, ss.5553-5562, 2026 (SCI-Expanded, Scopus)
  3. Screening of osteoporosis in patients with ANCA-associated vasculitis (AAV) is quite low: results from a country-wide studyDEMİRCİ YILDIRIM T., Erpek E., Ulusoy B. Ö., Uzun G. S., YAZICI A., Kardaş R. C., et al.Internal and Emergency Medicine, cilt.21, sa.5, ss.1647-1654, 2026 (SCI-Expanded, Scopus)
  4. T2 signal ratio enhances the diagnostic performance of apparent diffusion coefficient in differentiating orbital lymphoma from inflammatory mimickersBULUT E. G., Gümeler E., Karakaya J., KILIÇ L., KARADAĞ Ö., KARLI OĞUZ H. K.Diagnostic and Interventional Radiology, cilt.32, sa.4, ss.457-462, 2026 (SCI-Expanded, Scopus, TRDizin)
  5. Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritisALİBAZ F., Kara M., ESATOĞLU S. N., KENAR ARTIN G., Uzun G. S., Ünlü B., et al.Clinical and Experimental Rheumatology, cilt.44, sa.4, ss.647-662, 2026 (SCI-Expanded, Scopus)
  6. Türkiye Romatoloji Derneği ANCA ilişkili (asosiye) vaskülitler hastalık yönetimi kılavuzuKaradag O., Duran E., Dağlı P. A., Gerçik Ö., Kardaş R. C., sahin d., et al.Ulusal Romatoloji Dergisi, cilt.18, sa.1, ss.10-23, 2026 (TRDizin)
  7. Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational studyGallina G. D., Lanzillotta M., Maggioni S., Cariddi A., Danè G., Bayındır Akbaş A. N., et al.Rheumatology (Oxford, England), cilt.65, sa.3, 2026 (SCI-Expanded, Scopus)
  8. Reply to "Correspondence on: EULAR/PRES endorsed recommendations for the management of FMF: 2024 update"ÖZEN S., GÜL A., Santos C. S., SAĞ E., Lachmann H. J., Deschner J. K., et al.Annals of the rheumatic diseases, cilt.85, sa.3, 2026 (SCI-Expanded, Scopus)
  9. Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registryAta E. B., KILIÇ L., Fırlatan Yazgan B., Kart Bayram S. G., Ekici M., Ünaldı E., et al.Clinical Rheumatology, cilt.45, sa.2, ss.781-789, 2026 (SCI-Expanded, Scopus)
  10. Relapse in adult idiopathic inflammatory myopathies: clinical predictors and the potential role of anti-NXP2 in a single-center retrospective cohort studyEKİCİ M., İçli İ. Y., YARDIMCI G. K., ÖZSOY Z., ÜNALDI E., Fırlatan B., et al.Clinical Rheumatology, 2026 (SCI-Expanded, Scopus)
  11. Türkiye Romatoloji Derneği ANCA ilişkili (asosiye) vaskülitler hastalık yönetimi kılavuzuKaradag O., Duran E., Dağlı P. A., Gerçik Ö., Kardaş R. C., sahin d., et al.Ulusal Romatoloji Dergisi, cilt.17, sa.3, ss.131-144, 2025 (Scopus, TRDizin)
  12. VALIDITY AND RELIABILITY OF THE TURKISH TRANSLATION OF THE ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOMES (AAV-PRO) QUESTIONNAIREBİLGİN E., ÖZTÜRK E., Erpek E., Kocaayan H., Kardas R. C., KÜÇÜK H., et al.ANNALS OF THE RHEUMATIC DISEASES, cilt.83, ss.2365, 2025 (SCI-Expanded, Scopus)
  13. A rare disease with many faces: a multicentre registry of IgG4-related disease in childrenKAYA AKCA Ü., KÖSE H., Kurt T., Ulu K., Guliyeva V., Kilbas G., et al.RHEUMATOLOGY, cilt.64, sa.4, ss.2185-2192, 2025 (SCI-Expanded, Scopus)
  14. Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity indexBahap-Kara M., SARIYILDIZ E., ZENGİN H. Y., KARADAĞ Ö., EKİNCİOĞLU A.RHEUMATOLOGY, cilt.64, sa.3, ss.1010-1018, 2025 (SCI-Expanded, Scopus)
  15. Idiopathic polyarteritis nodosa-does it still exist? Viewpoint 2: idiopathic polyarteritis nodosa is rare, but still existsKARADAĞ Ö.RHEUMATOLOGY, cilt.64, 2025 (SCI-Expanded, Scopus)
  16. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter StudyDi Matteo A., Di Donato S., Smerilli G., Becciolini A., Camarda F., Cauli A., et al.ARTHRITIS & RHEUMATOLOGY, cilt.77, ss.22-33, 2025 (SCI-Expanded, Scopus)
  17. Commentary on IgG4-related uveitis. A French cohort and literature reviewEKİCİ M., KADAYIFÇILAR S., BEZCİ AYGÜN F., KARADAĞ Ö.SEMINARS IN ARTHRITIS AND RHEUMATISM, cilt.69, 2024 (SCI-Expanded, Scopus)
  18. Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world dataAYAN G., BAŞARAN H. Ö., FIRLATAN B., KILIÇ L., BİLGİNER Y., ALİKAŞİFOĞLU M., et al.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.27, sa.11, 2024 (SCI-Expanded, Scopus)
  19. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsiesUzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Guresci S., KARDAŞ R. C., et al.RHEUMATOLOGY INTERNATIONAL, cilt.44, ss.2547-2554, 2024 (SCI-Expanded, Scopus)
  20. Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up StudyEdiboglu E. D., Cinar M., KOZACI L. D., SOLMAZ D., Sargin G., KARADAĞ Ö., et al.EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.11, sa.3, ss.364-370, 2024 (ESCI, TRDizin)
  21. Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registrySARIYILDIZ E., ÜNALDI E., KILIÇ L., KARADAĞ Ö., KALYONCU U., ERTENLİ A. İ., et al.Acta Medica, cilt.55, sa.3, ss.214-221, 2024 (TRDizin)
  22. Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational StudyMoroni L., Gallina G., Lanzillotta M., Maggioni S., Benanti G., Cariddi A., et al.ARTHRITIS & RHEUMATOLOGY, ss.5054-5057, 2024 (SCI-Expanded, Scopus)
  23. Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosisAKSOY A., Colak S., YAĞIZ B., COŞKUN B. N., Omma A., SARI A., et al.PHLEBOLOGY, cilt.39, ss.550-556, 2024 (SCI-Expanded, Scopus)
  24. Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up StudyBahap-Kara M., SARIYILDIZ E., YARDIMCI G. K., KARADAĞ Ö., EKİNCİOĞLU A.RHEUMATOLOGY AND THERAPY, cilt.11, sa.4, ss.1043-1055, 2024 (SCI-Expanded, Scopus)
  25. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyKARADAĞ Ö., BÖLEK E. Ç., AYAN G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.Arthritis and Rheumatology, cilt.76, sa.7, ss.1120-1129, 2024 (SCI-Expanded, Scopus)
  26. IMMUNOGLOBULIN G4-RELATED THORACIC DISEASE: CLINICAL AND RADIOLOGICAL FINDINGS OF A TURKISH COHORTAlkan A., DURHAN G., YARDIMCI G. K., Sertcelik U. O., Farisogullari B., Ariyurek M., et al.SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, cilt.41, sa.2, 2024 (SCI-Expanded, Scopus)
  27. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre studyDi Matteo A., Smerilli G., Di Donato S., Liu A. R., Becciolini A., Camarda F., et al.Annals of the Rheumatic Diseases, cilt.83, sa.7, ss.847-857, 2024 (SCI-Expanded, Scopus)
  28. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)Yildirim T. D., Erpek E., Ulusoy B. O., Unaldi E., Cagdas O. S., Kardas R. C., et al.ANNALS OF THE RHEUMATIC DISEASES, 2024 (SCI-Expanded, Scopus)
  29. CENTRAL NERVOUS SYSTEM INVOLVEMENT OF ANCA-ASSOCIATED VASCULITIS IN A SINGLE CENTER - HUVAC EXPERIENCEOzen N. P. A., Bilgin E., Duran E., TOPÇUOĞLU M. A., Arsava E. M., Gocmen R., et al.ANNALS OF THE RHEUMATIC DISEASES, 2024 (SCI-Expanded, Scopus)
  30. LONG-TERM FOLLOW-UP AND RESULTS OF CHILDHOOD-ONSET ENTHESITIS-RELATED ARTHRITIS AND POLYARTHRITIS: HUR-BIO EXPERIENCEAta E. B., Kilic L., Bilgin E., Uzun G. S., Ayan G., Ekici M., et al.ANNALS OF THE RHEUMATIC DISEASES, 2024 (SCI-Expanded, Scopus)
  31. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.Internal and Emergency Medicine, cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)
  32. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational studyGeraldes R., Santos M., Ponte C., Craven A., Barra L., Robson J. C., et al.Journal of Neurology, cilt.271, sa.6, ss.3309-3320, 2024 (SCI-Expanded, Scopus)
  33. REAL-LIFE DATA COMPARING THE LONG-TERM OUTCOME AND TREATMENT IN ADULT AND PEDIATRIC DADA2 PATIENTS: SINGLE CENTER EXPERIENCE OVER 10 YEARSAyan G., BAŞARAN H. Ö., BÖLEK E. Ç., FIRLATAN YAZGAN B., Bulat B., BATU AKAL E. D., et al.ANNALS OF THE RHEUMATIC DISEASES, ss.1113-1114, 2024 (SCI-Expanded, Scopus)
  34. DIFFERENCES IN THE CHARACTERISTICS OF D2T/ NOND2T-RA PATIENTS AND FACTORS ASSOCIATED WITH D2T-RA AT B/TSDMARD STARTEken A., Ayan G., Ozsoy Z., Uzun G. S., Ekici M., Unaldi E., et al.ANNALS OF THE RHEUMATIC DISEASES, 2024 (SCI-Expanded, Scopus)
  35. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.Clinical and experimental rheumatology, cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus)
  36. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control studyCulerrier J., Nguyen Y., KARADAĞ Ö., SÖZEN ŞAHNE B., Yildrim T. D., Ögüt T. S., et al.Rheumatology (United Kingdom), cilt.63, sa.4, ss.999-1006, 2024 (SCI-Expanded, Scopus)
  37. A close look at the nutritional status and mediterranean diet adherence in patients with behcet's syndromeERSOY N., BÖLEK E. Ç., Farisoǧullari B., Çinar N., Garipoǧlu G., Çolak S., et al.Mediterranean Journal of Nutrition and Metabolism, cilt.17, sa.1, ss.43-52, 2024 (ESCI, Scopus)
  38. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure RegistryKARADAĞ Ö., Farisogullari B., YAĞIZ B., Erden A., Ademoglu Z., Kimyon G., et al.Clinical and Experimental Rheumatology, cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus)
  39. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.Can Bostan Ö., Duran E., Tuncay G., Cihanbeylerden M., Karadag Ö., Damadoglu E., et al.The Journal of asthma : official journal of the Association for the Care of Asthma, cilt.60, sa.5, ss.931-937, 2023 (SCI-Expanded, Scopus)
  40. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.Annals of the rheumatic diseases, cilt.82, sa.4, 2023 (SCI-Expanded, Scopus)
  41. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.Grayson P. C., Ponte C., Suppiah R., Robson J. C., Gribbons K. B., Judge A., et al.Annals of the rheumatic diseases, cilt.81, sa.12, ss.1654-1660, 2022 (SCI-Expanded, Scopus)
  42. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.Ponte C., Grayson P. C., Robson J. C., Suppiah R., Gribbons K. B., Judge A., et al.Annals of the rheumatic diseases, cilt.81, sa.12, ss.1647-1653, 2022 (SCI-Expanded, Scopus)
  43. Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based studyDi Matteo A., Cipolletta E., Castaniti G. M. D., Smerilli G., Airoldi C., Aydin S. Z., et al.RHEUMATOLOGY, cilt.61, ss.4863-4874, 2022 (SCI-Expanded, Scopus)
  44. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological StudyÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.Cumhuriyet Tıp Dergisi (ELEKTRONİK), cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)
  45. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?Farisogullari B., Cuceoglu M., Oral H., Yardimci G. K., Bilginer Y., Ozen S., et al.Internal and emergency medicine, cilt.17, sa.6, ss.1599-1608, 2022 (SCI-Expanded, Scopus)
  46. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.Suppiah R., Robson J. C., Grayson P. C., Ponte C., Craven A., Khalid S., et al.Annals of the rheumatic diseases, cilt.81, sa.3, ss.321-326, 2022 (SCI-Expanded, Scopus)
  47. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.Robson J. C., Grayson P. C., Ponte C., Suppiah R., Craven A., Judge A., et al.Annals of the rheumatic diseases, cilt.81, sa.3, ss.315-320, 2022 (SCI-Expanded, Scopus)
  48. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis.Grayson P. C., Ponte C., Suppiah R., Robson J. C., Craven A., Judge A., et al.Annals of the rheumatic diseases, cilt.81, sa.3, ss.309-314, 2022 (SCI-Expanded, Scopus)
  49. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.Ytterberg S. R., Bhatt D. L., Mikuls T. R., Koch G. G., Fleischmann R., Rivas J. L., et al.The New England journal of medicine, cilt.386, sa.4, ss.316-326, 2022 (SCI-Expanded, Scopus)
  50. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.Farisoğulları B., Yardımcı G. K., Sarı A., Bilgin E., Bölek E. Ç., Duran E., et al.Clinical and experimental rheumatology, cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus)
  51. Successful treatment of penile Mondor's disease with infliximab in a patient with Behçet's disease.Özbek D. A., Bilgin E., Onur M. R., Karadağ Ö., Kiraz S.Rheumatology (Oxford, England), cilt.60, sa.11, 2021 (SCI-Expanded, Scopus)
  52. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis.Lanzillotta M., Della-Torre E., Wallace Z. S., Stone J. H., Karadag Ö., Fernández-Codina A., et al.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], cilt.21, sa.7, ss.1395-1401, 2021 (SCI-Expanded, Scopus)
  53. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?DURAN E., BİLGİN E., BÖLEK E. Ç., FIRAT O., BULUT E. G., KALYONCU U., et al.DRUG METABOLISM AND PERSONALIZED THERAPY, cilt.36, sa.2, ss.169-172, 2021 (Scopus)
  54. Is Takayasu's arteritis more severe in children?Bolek E., Kaya A., Sari A., Sag E., Demir S., Kilic L., et al.Clinical and experimental rheumatology, sa.2, ss.32-38, 2021 (SCI-Expanded, Scopus)
  55. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.Monti S., Craven A., Klersy C., Montecucco C., Caporali R., Watts R., et al.Rheumatology (Oxford, England), cilt.60, sa.2, ss.617-628, 2021 (SCI-Expanded, Scopus)
  56. Mediastinal mass in a patient with rheumatoid arthritis: lymphoid cystic thymic hyperplasiaORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., Serkan U., et al.RHEUMATOLOGY ADVANCES IN PRACTICE, cilt.5, sa.2, 2021 (ESCI, Scopus)
  57. Predictive factors for work-day loss in Behcet's syndrome: A multi-center studyMUMCU G., Yay M., Aksoy A., Tas M. N., ARMAĞAN B., SARI A., et al.INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus)
  58. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2Ozen S., Bilginer Y., Batu E., Taşkıran E., Özkara H. A., Ünal Ş., et al.JOURNAL OF RHEUMATOLOGY, cilt.47, sa.1, ss.117-125, 2020 (SCI-Expanded, Scopus)
  59. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?Koca M., Erden A., Armagan B., Sari A., Yildiz F., Ozdamar S., et al.Acta clinica Belgica, cilt.74, sa.6, ss.451-455, 2019 (SCI-Expanded, Scopus)
  60. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritisanti-TNFDuran E., Yildirim B. E. S., KARADAĞ Ö.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.5, sa.9, 2019 (SCI-Expanded, Scopus)

All 73 on AVESİS →

Conference papers 143

  1. IgG4-Related Pachymeningitis: How Do I Recognize?ARSLAN D., Yardimci G., BABAOĞLU B., BÖLEK E. Ç., KILIÇ L., Saglam A., et al.9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.656, (Özet Bildiri)
  2. FACTORS ASSOCIATED WITH PERSISTENTLY HIGH HAQ-DI SCORE IN RA PATIENTS UNDER B/ TSDMARDS: LONGITUDINAL ANALYSIS OF HURBIO SINGLE CENTER REGISTRYBİLGİN E., GÜVEN E., FIRLATAN B., Ekici M., Bayram G. S. K., Unaldi E., et al.European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.500, (Özet Bildiri)
  3. ROMATOİD ARTRİTLİ BİR HASTADA MEDİASTİNAL KİTLE: LENFOİD KİSTİK TİMİK HİPERPLAZİORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., UYSAL S., et al.14. Anadolu Romatoloji Günleri, Online Kongre, 26 - 30 Mayıs 2021, (Özet Bildiri)
  4. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTSYardimci G. K., Farisogullari B., Armagan B., Bilgin E., Bolek E. C., Duran E., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri)
  5. SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDYKaradag O., Bolek E. C., Furuta S., Emmi G., Hocevar A., Hinojosa-Azaola A., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1060-1061, (Özet Bildiri)
  6. BIOSIMILAR INFLIXIMAB EXPERIENCE IN SPONDYLOARTRITIS PATIENTS: TREASURE REAL LIFE RESULTSBilge N. S. Y., Kasifoglu T., Kiraz S., Ertenli A. I., Dalkilic E., Bes C., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1616, (Özet Bildiri)
  7. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTSArmagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri)
  8. LOCALISATION OF RHEUMATOID LUNG NODULES IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: RIGHT OR LEFT?Bilgin E., Ekici M., Baytar Y., Duran E., Durhan G., Bolek E. C., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.277, (Özet Bildiri)
  9. EMERGING AUTOANTIBODIES PANEL (MYOSITIS ASSOCIATED AND MYOSITIS SPECIFIC ANTIBODIES) IN INFLAMMATORY MYOPATHIES: THE FREQUENCIES OF AND RELATIONSHIP WITH CLINICAL FEATURESYardimci G. K., Erul E., Bilgin E., Farisogullari B., Kilic L., Saribas Z., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1605-1606, (Özet Bildiri)
  10. CONCOMITANT USE OF BIOLOGIC DMARDS WITH CSDMARDS INCREASES DRUG RETENTION RATE AND IMPROVES TREATMENT RESPONSE IN THE PSORIATIC ARTHRITIS. HUR-BIO REAL LIFE RESULTSDuran E., Bilgin E., Bolek E. C., Yardimci G. K., Farisogullari B., Kilic L., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.757, (Özet Bildiri)
  11. CONVENTIONAL SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS - CHANGING PRACTICE IN BIOLOGIC ERA: REAL-LIFE RESULTS FROM HURBIO-PSA REGISTRYBilgin E., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., Kilic L., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1663, (Özet Bildiri)
  12. EFFICACY, RETENTION RATE AND PREDICTORS OF TOFACITINIB EFFICACY AND RETENTION IN RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL-LIFE EXPERIENCEBilgin E., Ceylan F., Bolek E. C., Duran E., Farisogullari B., Yardimci G. K., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1460, (Özet Bildiri)
  13. PREDICTORS AND SEVERITY OF POST-THROMBOTIC SYNDROME IN VASCULAR BEHCET'S DISEASE: RETROSPECTIVE MULTICENTER STUDYAksoy A., Colak S., Yagiz B., Seniz B. N., Omma A., Yildiz Y., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.367-368, (Özet Bildiri)
  14. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASEKalyoncu U., Ekici M., Bilgin E., Sari A., Baytar Y., Bolek E. C., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri)
  15. INFLAMMATORY ORBITAL DISEASES: THE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CENTREAksun M. S., Sahin T. K., Bolek E. C., Kilic L., Bulut E. G., Oguz K. K., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1806-1807, (Özet Bildiri)
  16. INCIDENCE RATE OF HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS UNDER TOFACITINIB: REAL-LIFE DATA FROM TURKEY - HURBIO REGISTRYBilgin E., Ceylan F., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., et al.Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.636, (Özet Bildiri)
  17. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life ResultsFARİSOĞULLARI B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.2019 ACR/ARP Annual Meeting, 8 - 13 Kasım 2019, (Özet Bildiri)
  18. Behçet Hastalığı’nda Hastaların Akdeniz Diyeti Uyumlarının Değerlendirilmesi veAntropometrik Ölçümlerine İncelenmesi: Kesitsel Pilot ÇalışmaERSOY N., BÖLEK E. Ç., Farisoğulları B., BİLGİN E., GARİPOĞLU G., KILIÇ L., et al.20. Ulusal RomatolojiKongresi, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)
  19. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimiERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)
  20. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTSYARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri)
  21. OFF-LABEL USE OF BIOLOGICAL THERAPIES IN RELAPSING AND/OR REFRACTORY POLYARTERITIS NODOSACanzian A., KARADAĞ Ö., Contis A., Maurier F., Sartorelli S., Denis L., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1186-1187, (Özet Bildiri)
  22. IS THERE AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES WITH IGG4-RELATED DISEASE OR NOT?ERDEN A., BÖLEK E. Ç., YARDIMCI G. K., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.990, (Özet Bildiri)
  23. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASEARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri)
  24. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITISBilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri)
  25. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITYARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri)
  26. VALIDATION OF A NOVEL DISEASE CLASSIFICATION IN HACETTEPE TAKAYASU ARTERITIS COHORTBÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1192, (Özet Bildiri)
  27. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATAKucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri)
  28. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGINBİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri)
  29. VALIDITY OF ACR/EULAR 2017 PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS IN TURKISH PATIENTS AND COMPARISON WITH 1990 CRITERIAYardimci G., BİLGİN E., ARMAĞAN B., Farisogullari B., KILIÇ L., AKDOĞAN A., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.39, (Özet Bildiri)
  30. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTSARMAĞAN B., YILDIRIM A., Onur M., Yardimci G., KILIÇ L., KALYONCU U., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  31. PEDIATRIC TO ADULT RHEUMATOLOGY CARE TRANSITION PROGRAMME OF HACETTEPE UNIVERSITY: VASCULITIDES PERSPECTIVEBÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  32. ARE CHILDHOOD-ONSET AND ADULT-ONSET TAKAYASU ARTERITIS SIMILAR IN TERMS OF CLINICAL FEATURES AND DISEASE COURSE?Cagri E., Demir B. S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.63, (Özet Bildiri)
  33. ASSESSMENT OF DAMAGE AND PROGNOSIS IN PATIENTS WITH ADULT IGA VASCULITIS: A RETROSPECTIVE MULTICENTERED COHORT STUDYGazel U., Omma A., SARI A., Cansu D. U., YAZICI A., Cefle A. E., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  34. CEREBROVASCULAR EVENT CAN BE THE PRESENTING FEATURE OF TAKAYASU ARTERITIS: RESULTS OF A PROSPECTIVE VASCULITIS CENTERSARI A., BÖLEK E. Ç., KILIÇ L., ARSAVA E. M., TOPÇUOĞLU M. A., KALYONCU U., et al.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  35. SECONDARY VASCULITIS DUE TO SINGLE GENE DEFECTSÖZEN S., BİLGİNER Y., Batu E., KARADAĞ Ö., ALİKAŞİFOĞLU M.19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
  36. Anevrizması olan Behçet hastalar›n tedavisi, prognozu ve mortalitesiArmagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.XIX. Ulusal Romatoloji Kongresi2, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri)
  37. Evaluation of patients with the diagnosis of vasculitis admitted to a medical ICUORTAÇ ERSOY N. E., ÖZEN S., ER B., ÖCAL S., ERDEN A., YARDIMCI G. K., et al.LIVES, 2018, 20 - 24 Ekim 2018, (Özet Bildiri)
  38. The Existence Of Exosomal MiRNAs In The Circulation In Familial Mediterranean Fever (FMF) Patientstavukcuoglu z., AKKAYA ULUM Z. Y., YERSAL N., AKBABA T. H., yardimci g. k., karadag o., et al.EBML Symposia, 3 - 06 Ekim 2018, (Özet Bildiri)
  39. Spinal Cord Involvement in Behcet’xxs Disease-Experience of a Vasculitis Centre at Silk RoadBÖLEK E. Ç., SARI A., KILIÇ L., AKDOĞAN A., TUNCER M. A., KARADAĞ Ö.ACR 2018, 20 - 24 Ekim 2018, cilt.70, ss.1806, (Tam Metin Bildiri)
  40. Arteriyel anevrizması olan Behçet hastalarnın klinik özellikleriArmagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.XIX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.68-69, (Özet Bildiri)
  41. FREQUENCY OF PULMONARY HYPERTENSION IN BEHCET'S DISEASEArmagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1471, (Özet Bildiri)
  42. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCESonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri)
  43. IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDYAlibaz-Oner F., Balci M. A., Pamuk O. N., Zengin O., Tasci M., Dogru A., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1118-1119, (Özet Bildiri)
  44. IDIOPATHIC GRANULOMATOUS MASTITIS MAY RESPONSE WELL TO COMBINATION OF IMMUNOSUPRESIVES AND GLUCOCORTICOIDSSari A., Konan A., Akpinar M., Armagan B., Erden A., Kilic L., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1152-1153, (Özet Bildiri)
  45. WHICH ONE IS MORE VALUABLE FOR DIAGNOSIS OF ADULT ONSET STILL'S DISEASE? SOLELY NEUTROPHILIA OR LEUKOCYTOSIS WITH NEUTROPHILIA?Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1150, (Özet Bildiri)
  46. HOW TO DIFFERENTIATE ADULT ONSET STILL'S DISEASE FROM OVERALL OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY FROM A TERTIARY REFERRAL CENTREBİLGİN E., Erden A., Armagan B., KILIÇ L., Sari A., YARDIMCI G. K., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1156-1157, (Özet Bildiri)
  47. ASSESSMENT OF DAMAGE AND PROGNOSIS IN PATIENTS WITH ADULT IGA VASCULITIS: RETROSPECTIVE MULTICENTERED COHORT STUDYAlibaz-Oner F., Omma A., Sari A., Gazel U., Cansu D. U., YAZICI A., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1474-1475, (Özet Bildiri)
  48. FOUR YEARS OF DELAY IN THE DIAGNOSIS OF SAPHO SYNDROME: SINGLE TERTIARY CENTRE EXPERIENCEErden A., Ekici M., Armagan B., Sari A., Yardimci G. K., Kilic L., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1552, (Özet Bildiri)
  49. RETENTION RATES OF CERTOLIZUMAB PEGOL IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTSArmagan B., Sari A., Erden A., Yardimci G. K., Kilic L., Kalyoncu U., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1001-1002, (Özet Bildiri)
  50. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRYKalvoncu U., Kiraz S., Bilgen S. A., Karadag O., Akdogan A., Kilic L., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1601-1602, (Özet Bildiri)
  51. COMPARISON OF CUT-OFF VALUES FOR FERRITIN TO DISCRIMINATE ADULT ONSET STILL'S DISEASE FROM OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDYBilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1675, (Özet Bildiri)
  52. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTSKilic L., Karadag O., Erden A., Sari A., Armagan B., Firat E., et al.Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.437-438, (Özet Bildiri)
  53. ANKİLOZAN SPONDİLİTTE EKLEM MOBİLİTESİNİN BİREYLERİN SAĞLIK ALGISINA ETKİSİNİN İNCELENMESİARIN G., TÜRKMEN N. B., OFLAZ F. B., ERDEN A., KARADAĞ Ö., GÖKSÜLÜK D., et al.3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)
  54. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life ExperiencesUYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  55. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial SpondyloarthritisSARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  56. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  57. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish CohortsKARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  58. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life ResultsARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
  59. Sjögren Sendromu’nun Kas Güçsüzlüğü ile Prezantasyonu: Renal Tubuler Asidoz Tip 1BÖLEK E. Ç., ERDEN A., KOÇ H., KARADAĞ Ö., KALYONCU U., KİRAZ S., et al.19.Ulusal İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Tam Metin Bildiri)
  60. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)

All 143 on AVESİS →

Контакты

Отделение
Ревматология, Больница для взрослых
Владение языками
English

Последнее обновление: